Company Filing History:
Years Active: 1994-2007
Title: Mark Hurle: Innovator in Enzyme Technology
Introduction
Mark Hurle is a distinguished inventor based in Bridgeport, PA (US). He has made significant contributions to the field of enzyme technology, particularly in the production of 2-keto-L-gulonic acid, a precursor of ascorbic acid (vitamin C). With a total of 4 patents to his name, Hurle's work has implications for both the pharmaceutical and food industries.
Latest Patents
Among his latest patents, Hurle has developed mutants of 2,5-diketo-D-gluconic acid reductase A. This enzyme is crucial for the production of 2-keto-L-gulonic acid. The mutants are prepared through site-directed mutagenesis, resulting in increased catalytic activity, enhanced expression levels, and improved temperature stability. These advancements are expected to optimize the production processes for vitamin C.
Career Highlights
Mark Hurle is affiliated with Rutgers, the State University of New Jersey, where he continues to innovate in enzyme research. His work has garnered attention for its potential applications in various industries, showcasing his commitment to advancing scientific knowledge and practical solutions.
Collaborations
Hurle collaborates with notable colleagues, including Robert A Lazarus and Stephen P Anderson. Their combined expertise contributes to the success of their research initiatives and patent developments.
Conclusion
Mark Hurle's contributions to enzyme technology and his innovative patents highlight his role as a key figure in the field. His work not only advances scientific understanding but also has practical applications that can benefit various industries.